Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does PALBOCICLIB Cause Red blood cell count decreased? 1,800 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 1,800 reports of Red blood cell count decreased have been filed in association with PALBOCICLIB (Ibrance). This represents 2.0% of all adverse event reports for PALBOCICLIB.

1,800
Reports of Red blood cell count decreased with PALBOCICLIB
2.0%
of all PALBOCICLIB reports
76
Deaths
321
Hospitalizations

How Dangerous Is Red blood cell count decreased From PALBOCICLIB?

Of the 1,800 reports, 76 (4.2%) resulted in death, 321 (17.8%) required hospitalization, and 18 (1.0%) were considered life-threatening.

Is Red blood cell count decreased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for PALBOCICLIB. However, 1,800 reports have been filed with the FAERS database.

What Other Side Effects Does PALBOCICLIB Cause?

Fatigue (15,190) White blood cell count decreased (11,273) Neoplasm progression (10,885) Death (8,410) Nausea (8,189) Neutropenia (6,423) Alopecia (6,201) Diarrhoea (5,635) Asthenia (3,660) Off label use (3,405)

What Other Drugs Cause Red blood cell count decreased?

LENALIDOMIDE (1,946) NIRAPARIB (1,351) CLOZAPINE (1,075) RUXOLITINIB (962) RIBAVIRIN (691) ADALIMUMAB (639) PEGINTERFERON ALFA-2A (579) VENETOCLAX (498) METHOTREXATE (469) RITUXIMAB (446)

Which PALBOCICLIB Alternatives Have Lower Red blood cell count decreased Risk?

PALBOCICLIB vs PALIPERIDONE PALBOCICLIB vs PALIVIZUMAB PALBOCICLIB vs PALONOSETRON PALBOCICLIB vs PAMIDRONATE PALBOCICLIB vs PAMIDRONIC ACID

Related Pages

PALBOCICLIB Full Profile All Red blood cell count decreased Reports All Drugs Causing Red blood cell count decreased PALBOCICLIB Demographics